Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review
Nirmatrelvir/Ritonavir is an oral treatment for mild to moderate COVID-19 cases with a high risk for a severe course of the disease. For this paper, a comprehensive literature review was performed, leading to a summary of currently available data on Nirmatrelvir/Ritonavir’s ability to reduce the ris...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2024-01-01
|
| Serija: | Advances in Respiratory Medicine |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2543-6031/92/1/9 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|